Table 1 Summary of clinical data for squamous cell carcinomas
Age | 24–92 (∼55 years) |
Survival (weeks) | 0.3–284 |
Gender | 60% female |
40% male | |
Lymph node | 65% (17/26) |
Grade | 77% moderately differentiated |
13% well differentiated | |
10% poorly differentiated |
Age | 24–92 (∼55 years) |
Survival (weeks) | 0.3–284 |
Gender | 60% female |
40% male | |
Lymph node | 65% (17/26) |
Grade | 77% moderately differentiated |
13% well differentiated | |
10% poorly differentiated |